본문 바로가기
KERD
논문KCI 등재

Patent Foramen Ovale: Story Closed?

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류신경과학

초록

The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess of complications in the interventional arm, two large recent trials suggest a benefit with regard of preventing further ischemic strokes. With this discrepancy in results it is important to discuss recent trials in detail and evolve an informed clinical approach for daily practice.

Abstract

The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess of complications in the interventional arm, two large recent trials suggest a benefit with regard of preventing further ischemic strokes. With this discrepancy in results it is important to discuss recent trials in detail and evolve an informed clinical approach for daily practice.

참고문헌 (32)

  1. Hagen PT, "Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts", Mayo Clin Proc, 59, pp.17~20 (1984)
  2. Thompson T, "Paradoxical embolism", QJM, os-23, pp.135~150 (1930)
  3. Di Tullio M, "Patent foramen ovale as a risk factor for cryptogenic stroke", Ann Intern Med, 117, pp.461~465 (1992)
  4. Lechat P, "Prevalence of patent foramen ovale in patients with stroke", N Engl J Med, 318, pp.1148~1152 (1988)
  5. Webster MW, "Patent foramen ovale in young stroke patients", Lancet, 2, pp.11~12 (1988)
  6. Mazzucco S, "Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis", Lancet Neurol, 17, pp.609~617 (2018)
  7. Mas JL, "Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both", N Engl J Med, 345, pp.1740~1746 (2001)
  8. Overell JR, "Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies", Neurology, 55, pp.1172~1179 (2000)
  9. Agarwal S, "Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism", JACC Cardiovasc Interv, 5, pp.777~789 (2012)
  10. Almekhlafi MA, "Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis", Neurology, 73, pp.89~97 (2009)
  11. Katsanos AH, "Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis", Stroke, 45, pp.3352~3359 (2014)
  12. Furlan AJ, "Closure or medical therapy for cryptogenic stroke with patent foramen ovale", N Engl J Med, 366, pp.991~999 (2012)
  13. Meier B, "Percutaneous closure of patent foramen ovale in cryptogenic embolism", N Engl J Med, 368, pp.1083~1091 (2013)
  14. Carroll JD, "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", N Engl J Med, 368, pp.1092~1100 (2013)
  15. Saver JL, "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke", N Engl J Med, 377, pp.1022~1032 (2017)
  16. Kent DM, "Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials", J Am Coll Cardiol, 67, pp.907~917 (2016)
  17. Mas JL, "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke", N Engl J Med, 377, pp.1011~1021 (2017)
  18. Søndergaard L, "Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 377, pp.1033~1042 (2017)
  19. Lee PH, "Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial", J Am Coll Cardiol, 71, pp.2335~2342 (2018)
  20. Stortecky S, "Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis", Eur Heart J, 36, pp.120~128 (2015)
  21. Mir H, "Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network metaanalysis incorporating complementary external evidence", BMJ Open, 8, pp.e023761~ (2018)
  22. Turc G, "Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study", J Am Heart Assoc, 7, pp.e008356~ (2018)
  23. Diener HC, "Closure of patent foramen ovale and cryptogenic stroke: unresolved issues", Curr Neurol Neurosci Rep, 18, pp.92~ (2018)
  24. Kasner SE, "Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial", Lancet Neurol, 17, pp.1053~1060 (2018)
  25. Kuijpers T, "Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline", BMJ, 362, pp.k2515~ (2018)
  26. Pristipino C, "European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism", Eur Heart J (2018)[DOI]
  27. "Dieses Schirmchen rettet Leben" (2014)[URL]
  28. De Rosa S, "Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis", Ann Intern Med, 168, pp.343~350 (2018)
  29. Mojadidi MK, "Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated metaanalysis of randomized trials", JACC Cardiovasc Interv, 10, pp.2228~2230 (2017)
  30. Shah R, "Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis", Ann Intern Med, 168, pp.335~342 (2018)
  31. Saver JL, "Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review", Stroke, 49, pp.1541~1548 (2018)
  32. Merkler AE, "Safety outcomes after percutaneous transcatheter closure of patent foramen ovale", Stroke, 48, pp.3073~3077 (2017)

관련 논문AI추천

Patent Foramen Ovale and Stroke–Current StatusJi Won Kim, Mi ji Lee, Oh Young Bang, Sookyung Ryoo, Suk Jae Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2015 · 제17권 제3호Cerebrovascular Events in Older Patients With Patent Foramen Ovale: Current Status and Future PerspectivesChamorro Angel, Farjat-Pasos Julio I., Houde Christine, Lanthier Sylvain, Mengi Siddhartha, Robichaud Mathieu, Rodés-Cabau Josep대한뇌졸중학회 · 대한뇌졸중영문학회지2023 · 제25권 제3호Transcatheter Patent Foramen Ovale Closure in Stroke Patients with Thrombophilia: Current Status and Future PerspectivesChristine Houde, Jorge Nuche, Josep Rodés-Cabau, Jules Mesnier, Julio I. Farjat-Pasos, Stephanie Cloutier, Vassili Panagides대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제3호Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale허란, 김영대, 김중선, 이상엽, Bum Joon Kim, Byung Joo Sun, Jae-Kwan Song, Jang-Whan Bae, Jeong Yoon Jang, Ji Sung Lee, Jong Shin Woo, Jong S. Kim, Jung-Won Suh, Jun Yup Kim, Kyusup Lee, Pil Hyung Lee, Soe Hee Ann, Soo Jeong, Sung Hyuk Heo, Sun U. Kwon대한뇌졸중학회 · 대한뇌졸중영문학회지2024 · 제26권 제2호Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO TrialDong-Wha Kang, Hanim Kwon, Jae-Kwan Song, Jong S. Kim, Pil Hyung Lee, Sun U. Kwon대한뇌졸중학회 · 대한뇌졸중영문학회지2021 · 제23권 제2호Patent Foramen Ovale Closure: Opportunity Closed in Old Patients?Jong S. Kim, Keun-Sik Hong대한뇌졸중학회 · 대한뇌졸중영문학회지2021 · 제23권 제2호

이 간행물의 다른 논문 (14건)